
January 5, 2023
Immune system B-cells can help predict HER2-positive breast cancer treatment response
Researchers report specific immune system cells can help them determine whether HER2-positive breast cancer will respond to treatment.
January 5, 2023
Researchers report specific immune system cells can help them determine whether HER2-positive breast cancer will respond to treatment.
October 3, 2022
The National Cancer Institute has awarded the UNC Lineberger Pancreatic Cancer Center of Excellence a five-year, $10.9 million Pancreatic Cancer Specialized Program of Research Excellence (SPORE) grant.
September 26, 2022
The NCI awarded $9.3 million in support of two five-year research projects from researchers in the UNC Lineberger Pancreatic Cancer Center of Excellence in partnership with other institutions.
December 3, 2020
Researchers at the University of North Carolina and North Carolina State University have developed a computational framework to generate evidence-based optimal cancer treatment decisions informed by a patient’s genomic biomarkers.